Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice. Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.
Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice. The main purpose of this study is to: * Assess HBP control status in each Asian country * Develop an Asian consensus and Asia-specific treatment for hypertension * Improve the management of hypertension in Asia by encouraging patients to monitor HBP
Study Type
OBSERVATIONAL
Enrollment
1,462
We ask participants to measure their home blood pressure 7 days or more.
Jichi Medical University
Tochigi, Japan
Distribution rate based on the home BP of the patients.
Distribution rate based on the home BP of the patients who are defined as: * Masked morning hypertension * White-coat hypertension * Poorly controlled hypertension * Well controlled hypertension
Time frame: 7 days or more blood pressure measurement
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.